Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease

Brain Research Bulletin

Volumn 88, Issue 2-3, 2012, Pages 223-236

  Fielding, Steven A ^a   Brooks, Simon P ^b   Klein, Alexander ^a   Bayram Weston, Zubeyde ^a   Jones, Lesley ^b   Dunnett, Stephen B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cognitive tests; Frontostriatal function; Huntingtin inclusions; Motor tests; Phenotype; TgHD rats

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DELAYED ALTERNATION; EXPERIMENTAL TEST; EXPLORATION OF NOVELTY TEST; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUNTINGTON CHOREA; MALE; MOTOR DYSFUNCTION; NONHUMAN; OBJECT RECOGNITION TEST; PRIORITY JOURNAL; RAT; RESPONSE TIME; ROTAROD TEST; SERIAL IMPLICIT LEARNING TASK; SEX DIFFERENCE; STAIRCASE REACHING TEST; TRANSGENIC HUNTINGTON DISEASE RAT; TRANSGENIC RAT; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; HUNTINGTON DISEASE; MALE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, TRANSGENIC; REACTION TIME;

EID: 84860835558     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.09.011     Document Type: Article

References (68)

1. Abrous D.N., Dunnett S.B. Skilled paw reaching in rats: the staircase test. Neurosci. Prot. 1994, 3:1-11.
2. J. Alberch, E. Pérez-Navarro, J.M. Canals, Animal models of Huntington's disease, in: L.R. Squire (Ed.), Encyclopedia of Neuroscience, Amsterdam, 2009, pp. 429-436.
3. Bauer A., Zilles K., Matusch A., Holzmann C., Riess O., von Hörsten S. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation. J. Neurochem. 2005, 94:639-650.
4. Bayram-Weston Z., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterisation of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice. Brain Res. Bull. 2012, 88:104-112.
5. Bayram-Weston Z., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterisation of the evolution of cellular pathology in the YAC128 transgenic mice. Brain Res. Bull. 2012, 88:137-147.
6. Bayram-Weston Z., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(Q92) Huntington's disease knock-in mice. Brain Res. Bull. 2012, 88:171-181.
7. Bayram-Weston Z., Torres E.M., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterisation of the evolution of cellular pathology in the Hdh(CAG(Q150)) Huntington's disease knock-in mouse. Brain Res. Bull. 2012, 88:182-188.
8. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci. 2004, 5:373-384.
9. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 2000, 20:4320-4324.
10. Bode F.J., Stephan M., Suhling H., Pabst R., Straub R.H., Raber K.A., Bonin M., Nguyen H.P., Riess O., Bauer A., Sjoberg C., Petersén Å., von Hörsten S. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 2008, 17:2595-2609.
11. Bode F.J., Stephan M., Wiehager S., Nguyen H.P., Björkqvist M., von Hörsten S., Bauer A., Petersen A. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model. Behav. Brain Res. 2009, 205:175-182.
12. Bowles K.R., Brooks S.P., Dunnett S.B., Jones L. Gene expression and behaviour in mouse models of HD. Brain Res. Bull. 2012, 88:276-284.
13. Brasted P.J., Döbrössy M.D., Robbins T.W., Dunnett S.B. Striatal lesions produce distinctive impairments in reaction time performance in two different operant chambers. Brain Res. Bull. 1998, 46:487-494.
14. Brooks S.P., Betteridge H., Trueman R.C., Jones L., Dunnett S.B. Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res. Bull. 2006, 69:452-457.
15. Brooks S.P., Higgs G.V., Jones L., Dunnett S.B. Longitudinal analysis of the behavioural phenotype in Hdh Q92 Huntington's disease knock-in mice. Brain Res. Bull. 2012, 88:148-155.
16. (CAG)150 Huntington's disease knock-in mice. Brain Res. Bull. 2012, 88:182-188.
17. Brooks S.P., Janghra N., Higgs G.V., Bayram-Weston Z., Heuer A., Jones L., Dunnett S.B. Selective cognitive impairment in the YAC128 Huntington's disease mouse. Brain Res. Bull. 2012, 88:121-129.
18. Brooks S.P., Jones L., Dunnett S.B. Longitudinal analysis of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line. Brain Res. Bull. 2012, 88:130-136.
19. Brooks S.P., Trueman R.C., Dunnett S.B. Striatal lesions in the mouse disrupt acquisition and retention, but not implicit learning, in the SILT procedural motor learning task. Brain Res. 2007, 1185:179-188.
20. Brooks S.P., Fielding S., Döbrössy M.D., von Hörsten S., Dunnett S.B. Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance. Brain Res. Bull. 2009, 79:310-315.
21. Brown V.J., Bowman E.M., Robbins T.W. Response-related deficits following unilateral lesions of the medial agranular cortex of the rat. Behav. Neurosci. 1991, 105:567-578.
22. Brown V.J., Robbins T.W. Elementary processes of response selection mediated by distinct regions of the striatum. J. Neurosci. 1989, 9:3760-3765.
23. Cao C., Temel Y., Blokland A., Ozen H., Steinbusch H.W., Vlamings R., Nguyen H.P., von Hörsten S., Schmitz C., Visser-Vandewalle V. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic rat model. Behav. Brain Res. 2006, 170:257-261.
24. Carli M., Evenden J.L., Robbins T.W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 1985, 313:679-682.
25. D. Craufurd, J.S. Snowden, Neuropsychological and neuropsychiatric aspects of Huntington's disease, in: G.P. Bates, P.S. Harper, A.L. Jones (Eds.), Huntington's Disease, Oxford, New York, 2002, pp. 62-94.
26. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions (NII) underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997, 90:537-548.
27. Divac I., Markowitsch H.J., Pritzel M. Behavioural and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Res. 1978, 151:523-532.
28. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., Bates G., Morton A.J. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp. Neurol. 1998, 154:31-40.
29. Dunnett S.B., Iversen S.D. Neurotoxic lesions of ventrolateral but not anteromedial neostriatum in rats impair differential reinforcement of low rates (DRL) performance. Behav. Brain Res. 1982, 6:213-226.
30. Dunnett S.B., Meldrum A., Muir J.L. Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat. Neuroscience 2005, 135:1055-1065.
31. Dunnett S.B., Nathwani F., Björklund A. The integration and function of striatal grafts. Prog. Brain Res. 2000, 127:345-380.
32. Dunnett S.B., Nathwani F., Brasted P.J. Medial prefrontal and neostriatal lesions disrupt performance in an operant delayed alternation task in rats. Behav. Brain Res. 1999, 106:13-28.
33. Eagle D.M., Humby T., Dunnett S.B., Robbins T.W. Effects of regional striatal lesions on motor, motivational and executive aspects of progressive ratio performance in rats. Behav. Neurosci. 1999, 113:718-731.
34. El Massioui N., Ouary S., Chéruel F., Hantraye P., Brouillet E. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid. Exp. Neurol. 2001, 172:172-181.
35. Faure A., Hohn S., von Horsten S., Delatour B., Raber K., Le Blanc P., Desvignes N., Doyere V., El Massioui N. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. Neurobiol. Learn. Mem. 2011, 95:92-101.
36. Frank S., Jankovic J. Advances in the pharmacological management of Huntington's disease. Drugs 2010, 70:561-571.
37. Fricker-Gates R.A., Smith R.A., Muhith J., Dunnett S.B. The role of pretraining on skilled forelimb use in an animal model of Huntington's disease. Cell Transplant. 2003, 12:257-264.
38. Hodos W., Kalman G. Effects of increment size and reinforcer volume on progressive ratio performance. J. Exp. Anal. Behav. 1963, 6:387-392.
39. Höhn S., Dallerac G., Faure A., Urbach Y.K., Nguyen H.P., Riess O., von Horsten S., Le Blanc P., Desvignes N., El Massioui N., Brown B.L., Doyere V. Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for Huntington disease. J. Neurosci. 2011, 31:8986-8997.
40. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
41. Jay J.R., Dunnett S.B. An operant serial implicit learning task (SILT) in rats: task acquisition, performance and the effects of striatal lesions. J. Neurosci. Meth. 2007, 163:235-244.
42. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., Turkoglu H.O., Rutten B.P., Visser-Vandewalle V., Steinbusch H.W., Blokland A., Korr H., Riess O., von Hörsten S., Schmitz C. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol. Dis. 2006, 22:538-547.
43. Kumar P., Kalonia H., Kumar A. Huntington's disease: pathogenesis to animal models. Pharmacol. Rep. 2010, 62:1-14.
44. Landles C., Sathasivam K., Weiss A., Woodman B., Moffitt H., Finkbeiner S., Sun B., Gafni J., Ellerby L.M., Trottier Y., Richards W.G., Osmand A., Paganetti P., Bates G.P. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J. Biol. Chem. 2010, 19:8808-8823.
45. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., Robbins T.W., Sahakian B.J. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998, 121:1329-1343.
46. Lawrence A.D., Watkins L.H.A., Sahakian B.J., Hodges J.R., Robbins T.W. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 2000, 123:1349-1364.
47. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends Pharmacol. Sci. 2002, 23:32-39.
48. Metz G.A., Whishaw I.Q. Skilled reaching an action pattern: stability in rat (Rattus norvegicus) grasping movements as a function of changing food pellet size. Behav. Brain Res. 2000, 116:111-122.
49. Monville C., Torres E.M., Dunnett S.B. Comparison of two different protocols of the rotarod test to assess motor deficit and lesion size in the 6-OHDA model. J. Neurosci. Meth. 2006, 158:219-223.
50. Morton A.J., Lagan M., Skepper J.N., Dunnett S.B. Progressive formation of inclusions in the brains of mice transgenic for the human Huntington's disease mutation parallels neurological decline. J. Neurocytol. 2000, 29:679-702.
51. Nguyen H.P., Kobbe P., Rahne H.M., Wörpel T., Jäger B., Stephan M., Pabst R., Holzmann C., Riess O., Korr H., Kántor O., Petrasch-Parwez E., Wetzel R., Osmand A.P., von Hörsten S. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum. Mol. Genet. 2006, 15:3177-3194.
52. Nonneman A.J., Corwin J.V. Differential effects of prefrontal cortex ablation in neonatal, juvenile, and young adult rats. J. Comp. Physiol. Psychol. 1981, 95:588-602.
53. T.W. Robbins, J.L. Muir, A.S. Killcross, D. Pretsell, Methods of assessing attention and stimulus control in the rat, in: A. Sahgal (Ed.), Behavioural Neuroscience: A Practical Approach, vol. I, Oxford, 1993, pp. 13-47.
54. Rohlf F.J., Sokal R.R. Statistical Tables 1995, Freeman, New York. 3rd ed.
55. Sanberg P.R., Fibiger H.C. Body weight, feeding and drinking behaviors in rats with kainic acid lesions of striatal neurons: with a note on body weight symptomatology in Huntington's disease. Exp. Neurol. 1978, 66:444-466.
56. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997, 90:549-558.
57. Smith D.L., Portier R., Woodman B., Hockly E., Mahal A., Klunk W.E., Li X.J., Wanker E., Murray K.D., Bates G.P. Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles. Neurobiol. Dis. 2001, 8:1017-1026.
58. Temel Y., Cao C., Vlamings R., Blokland A., Ozen H., Steinbusch H.W., Michelsen K.A., von Hörsten S., Schmitz C., Visser-Vandewalle V. Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington's disease. Neurosci. Lett. 2006, 406:138-141.
59. Trueman R.C., Brooks S.P., Dunnett S.B. Implicit learning in a serial choice visual discrimination task in the operant 9-hole box by intact and striatal lesioned mice. Behav. Brain Res. 2005, 159:313-322.
60. Trueman R.C., Brooks S.P., Jones L., Dunnett S.B. The operant serial implicit learning task reveals early-onset motor learning deficits in a knock-in mouse model of Huntington's disease. Eur. J. Neurosci. 2007, 25:551-558.
61. Q92/Q92 knock-in mouse model of Huntington's disease in the operant serial implicit learning task (SILT). Behav. Brain Res. 2008, 189:317-324.
62. Q92 knock-in mouse model of Huntington's disease. Behav. Brain Res. 2009, 203:215-222.
63. van Dellen A., Deacon R., York D., Blakemore C., Hannan A.J. Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Res. Bull. 2001, 56:313-318.
64. Vandeputte C., Taymans J.M., Casteels C., Coun F., Ni Y., Van Laere K., Baekelandt V. Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci. 2010, 11:92.
65. von Hörsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarman A., Rathke-Hartlieb S., Schulx J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer G.B., Bauer A., Li X.J., Riess O. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 2003, 12:617-624.
66. Vonsattel J.P., Myers R.H., Stevens T.J. Neuropathologic classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
67. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
68. Whishaw I.Q., Pellis S.M. The structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory component. Behav. Brain Res. 1990, 41:49-59.